Welcome to the TPD Summit 2026
The
Targeted Protein Degradation Summit 2026 is a premier global gathering of scientists, biotech leaders, and innovators transforming drug discovery through the degradation of disease-driving proteins.
Across two dynamic days in Barcelona, we'll dive deep into the latest advances in PROTACs, molecular glues, novel ligase targeting, and emerging platforms like LYTACs and DUBTACs. From early discovery to the clinic, the field is evolving rapidly - and this event is your opportunity to stay ahead, form partnerships, and help shape the future of small-molecule precision medicine.
The TPD Summit 2026
The
Targeted Protein Degradation (TPD) Barcelona Summit is Europe's premier event dedicated to accelerating the development of next-generation degrader therapeutics. This two-day summit brings together scientific leaders, drug discovery innovators, and industry decision-makers to explore cutting-edge advancements in PROTACs, molecular glues, E3 ligase modulation, and ubiquitin-proteasome system targeting.
From early discovery to translational research and clinical pipelines, the summit offers a deep dive into the strategies that are redefining precision medicine.
6 Key Themes for the TPD Summit 2026
- Innovations in Degrader Chemistry: Advancing bifunctional and monovalent degraders: PROTACs, glues, covalent binders
- Expanding the E3 Ligase Toolbox: Novel ligases, tissue specificity, and targeted degradation strategies
- Structural Biology & Rational Design: Ternary complex dynamics, modeling, and degrader-enabled selectivity
- PK/PD, Bioavailability & Drug-Like Properties: Oral delivery, blood–brain barrier access, and degradation kinetics
- Clinical Translation & Biomarker Strategies: First-in-human studies, pharmacodynamic endpoints, and trial design
- Emerging Modalities in Protein Degradation: LYTACs, AUTACs, DUBTACs, and new frontiers in subcellular targeting
Who Should Attend
- Medicinal Chemists & Structural Biologists: Driving rational degrader design and ligand discovery
- Drug Discovery Scientists & Pharmacologists: Exploring new modalities for undruggable targets
- Biotech & Pharma Executives: Leading R&D, BD, and clinical strategy in TPD programs
- Clinical Development Leaders: Advancing degraders through preclinical and early-phase trials
- Computational Biologists & Platform Engineers: Enabling in silico modeling, AI-driven design, and degrader screening
- Investors & Venture Capitalists: Seeking the next wave of innovation in oncology, neuro, and inflammation
- Regulatory & IP Professionals: Navigating new frameworks for novel mechanisms of action
Industries Represented
- Small Molecule Drug Discovery
- Biopharma & Degrader-Platform Biotech
- Structural & Computational Biology
- CROs & Preclinical Services
- Medicinal & Synthetic Chemistry
- Pharmaceutical IP & Legal
- Venture Capital & Strategic Partnerships
Speakers
- Dr. Luka Nicin, Investor
- Zhiyong Wang, Founder & CSO Venquis Therapeutics
- Ingeborg Hers, Professor in Pharmacology and Cell Signaling University of Bristol
- Raquel R. Mura, Founder GM Life Sciences Consulting
- Dr. Marc Arago, Mechanisms of Disease IRB
- Jason Xiang, CEO & Founder Polymed Biopharmaceuticals, Inc.
- Dr Adam Yip, Director, Drug Discovery Ternary Tx
- Juhani Lahdenperä, COO RNatives Inc
- Victor GuallarI, CREA Research Professor, BSCCSO, Nostrum Biodiscovery
- Yusuke Tominari, Co-founder, CEO Azuriris, Inc.
- Jing Li, Principal Scientist Biochemical and Cellular Pharmacology Genentech, A Member of the Roche Group
- Giulia Apprato, Molecular Biotechnology, Diagnostics and Drug Discovery Università di Torino
- Emiliano Biasini, Associate Professor, Department CIBIO, University of Trento; Co-founder and Shareholder, Sibylla Biotech
- Miroslaw Janowski, Professor, Tenured, Co-Director, Program in Image Guided Neurointerventions (PIGN), Center for Advanced Imaging Research, University of Maryland
Please fill in your name and email to receive the Summit Agenda of this event.
Venue
Hotel SB Plaza Europa
Carrer de les Ciències 11, 13, L’Hospitalet de Llobregat, 08908
Barcelona, Spain
